Emergent BioSolutions CEO Robert Kramer's 2021 pay jumps 24% to $6.9M
Emergent BioSolutions reports 2021 executive compensation
By ExecPay News
Published: April 15, 2022
Emergent BioSolutions reported fiscal year 2021 executive compensation information on April 15, 2022.
In 2021, five executives at Emergent BioSolutions received on average a compensation package of $3.4M, a 9% increase compared to previous year.
Average pay of disclosed executives at Emergent BioSolutions
Robert Kramer, Chief Executive Officer, received $6.9M in total, which increased by 24% compared to 2020. 40% of Kramer's compensation, or $2.8M, was in stock awards. Kramer also received $900K in non-equity incentive plan, $2.2M in option awards, $1M in salary, as well as $6.4K in other compensation.
For fiscal year 2021, the median employee pay was $110,416 at Emergent BioSolutions. Therefore, the ratio of Robert Kramer's pay to the median employee pay was 63 to one.
Fuad El-Hibri, Chairman, received a compensation package of $3.5M, which increased by 9% compared to previous year. 37% of the compensation package, or $1.3M, was in stock awards.
Richard S. Lindahl, Chief Financial Officer, earned $2.2M in 2021, a 4% decrease compared to previous year.
Adam Havey, Chief Operating Officer, received $2.1M in 2021, which decreases by 4% compared to 2020.
Atul Saran, Executive Vice Presidentand Chief Strategy andand Development Officer, earned $2.1M in 2021, a 4% decrease compared to previous year.
Related executives
Fuad El-Hibri
Emergent BioSolutions
Chairman
Robert Kramer
Emergent BioSolutions
Chief Executive Officer
Richard Lindahl
Emergent BioSolutions
Chief Financial Officer
Adam Havey
Emergent BioSolutions
Chief Operating Officer
Atul Saran
Emergent BioSolutions
Executive Vice Presidentand Chief Strategy andand Development Officer
You may also like
Source: SEC filing on April 15, 2022.